Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Tarendeep Thind's research focuses on venous thromboembolism (VTE) prophylaxis, particularly in trauma patients. Thind has investigated weight-based dosing strategies for low-molecular-weight heparin, such as enoxaparin, to optimize VTE prevention in this patient population. Studies have examined the safety and efficacy of these dosing methods in spinal trauma patients and in the broader context of trauma care. The research also extends to readmission patterns following traumatic brain injury, utilizing large datasets to understand patient outcomes. Thind has collaborated with several researchers at the University of Arkansas for Medical Sciences on these investigations, contributing to a growing body of work on critical care and patient safety.
Metrics
- h-index: 2
- Publications: 4
- Citations: 12
Selected Publications
-
Corrigendum to “Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe” [Journal of Surgical Research 2023, Volume 290, October 2023, Pages 209-214] (2025)
-
Readmissions After Traumatic Brain Injury in the Nationwide Readmissions Database (2024)
-
Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients (2024)
-
Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe (2023)
Collaboration Network
Top Collaborators
- Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients
- Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe
- Readmissions After Traumatic Brain Injury in the Nationwide Readmissions Database
- Corrigendum to “Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe” [Journal of Surgical Research 2023, Volume 290, October 2023, Pages 209-214]
- Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients
- Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe
- Readmissions After Traumatic Brain Injury in the Nationwide Readmissions Database
- Corrigendum to “Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe” [Journal of Surgical Research 2023, Volume 290, October 2023, Pages 209-214]
- Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients
- Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe
- Corrigendum to “Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe” [Journal of Surgical Research 2023, Volume 290, October 2023, Pages 209-214]
- Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients
- Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe
- Corrigendum to “Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe” [Journal of Surgical Research 2023, Volume 290, October 2023, Pages 209-214]
- Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients
- Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe
- Corrigendum to “Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe” [Journal of Surgical Research 2023, Volume 290, October 2023, Pages 209-214]
- Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe
- Readmissions After Traumatic Brain Injury in the Nationwide Readmissions Database
- Corrigendum to “Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe” [Journal of Surgical Research 2023, Volume 290, October 2023, Pages 209-214]
- Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients
- Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe
- Corrigendum to “Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe” [Journal of Surgical Research 2023, Volume 290, October 2023, Pages 209-214]
- Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients
- Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients
- Readmissions After Traumatic Brain Injury in the Nationwide Readmissions Database
- Readmissions After Traumatic Brain Injury in the Nationwide Readmissions Database
- Readmissions After Traumatic Brain Injury in the Nationwide Readmissions Database
- Readmissions After Traumatic Brain Injury in the Nationwide Readmissions Database
- Readmissions After Traumatic Brain Injury in the Nationwide Readmissions Database
- Readmissions After Traumatic Brain Injury in the Nationwide Readmissions Database
Similar Researchers
Based on overlapping research topics